Medexus Pharmaceuticals Inc.

Medexus Pharmaceuticals Inc.verified

MEDXF

Price:

$1.93

Market Cap:

$62.72M

Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. It focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, and allergy. The company's primary products are Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B; and Rupall, a prescription allergy medication. Its products portfolio also includes Treosulfan, a bifunctional alkylating agent for allogeneic hematopoietic stem cell transplantation; Trispan, a...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2017-11-27

Stock Exchange

OTC

Ticker

MEDXF

The PE Ratio as of December 2025 (TTM) for Medexus Pharmaceuticals Inc. (MEDXF) is 193.00

According to Medexus Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 193.00. This represents a change of 290.40% compared to the average of 49.44 of the last 4 quarters.

Medexus Pharmaceuticals Inc. (MEDXF) Historical PE Ratio (quarterly & annually)

How has MEDXF PE Ratio performed in the past?

The mean historical PE Ratio of Medexus Pharmaceuticals Inc. over the last ten years is -18.81. The current 193.00 PE Ratio has changed -102715.67% with respect to the historical average. Over the past ten years (40 quarters), MEDXF's PE Ratio was at its highest in in the September 2024 quarter at 147.33. The PE Ratio was at its lowest in in the March 2025 quarter at -28.25.

Quarterly (TTM)
Annual

Average

-18.81

Median

-8.28

Minimum

-167.93

Maximum

27.81

Medexus Pharmaceuticals Inc. (MEDXF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Medexus Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 399.50%

Maximum Annual PE Ratio = 27.81

Minimum Annual Increase = -741.53%

Minimum Annual PE Ratio = -167.93

Quarterly (TTM)
Annual
YearPE RatioChange
202527.81-116.56%
2024-167.93-741.53%
202326.18-223.37%
2022-21.22399.50%
2021-4.25-44.38%
2020-7.64-14.44%
2019-8.93-10.26%
2018-9.95-32.82%
2017-14.81101.29%
2016-7.3618.38%

Medexus Pharmaceuticals Inc. (MEDXF) Average PE Ratio

How has MEDXF PE Ratio performed in the past?

The current PE Ratio of Medexus Pharmaceuticals Inc. (MEDXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-37.98

5-year avg

-27.88

10-year avg

-18.81

Medexus Pharmaceuticals Inc. (MEDXF) PE Ratio vs. Peers

How is MEDXF’s PE Ratio compared to its peers?

Medexus Pharmaceuticals Inc.’s PE Ratio is greater than Planet 13 Holdings Inc. (-1.16), greater than Decibel Cannabis Company Inc. (6.74), greater than Earth Science Tech, Inc. (15.05), greater than Flower One Holdings Inc. (-0.00), greater than TransCanna Holdings Inc. (-0.04), greater than Precision System Science Co., Ltd. (-20.32), greater than 1CM Inc. (10.13), greater than International Isotopes Inc. (-137.01), greater than Vext Science, Inc. (-2.46), greater than Nicox S.A. (-0.68),

Build a custom stock screener for Medexus Pharmaceuticals Inc. (MEDXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medexus Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medexus Pharmaceuticals Inc. (MEDXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medexus Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Medexus Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Medexus Pharmaceuticals Inc. (MEDXF)?

What is the highest PE Ratio for Medexus Pharmaceuticals Inc. (MEDXF)?

What is the 3-year average PE Ratio for Medexus Pharmaceuticals Inc. (MEDXF)?

What is the 5-year average PE Ratio for Medexus Pharmaceuticals Inc. (MEDXF)?

How does the current PE Ratio for Medexus Pharmaceuticals Inc. (MEDXF) compare to its historical average?